XML 13 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF NET INCOME (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Oct. 01, 2022
Sep. 25, 2021
Oct. 01, 2022
Sep. 25, 2021
Income Statement [Abstract]        
Net sales $ 658,880 $ 539,581 $ 1,900,646 $ 1,526,863
Cost of sales 402,059 325,009 1,122,258 954,429
Gross profit 256,821 214,572 778,388 572,434
Selling, general, and administrative expenses 90,219 67,468 258,820 199,071
Research and development expenses 25,752 15,779 68,796 46,912
Amortization of intangibles 15,567 10,446 39,883 31,608
Restructuring, impairment, and other charges 3,413 772 4,265 1,998
Total operating expenses 134,951 94,465 371,764 279,589
Operating income 121,870 120,107 406,624 292,845
Interest expense 8,399 4,602 17,069 13,901
Foreign exchange loss 18,191 3,154 40,051 8,315
Other (income) expense, net (698) (1,240) 9,789 (10,867)
Income before income taxes 95,978 113,591 339,715 281,496
Income taxes 20,510 21,537 59,713 49,634
Net income $ 75,468 $ 92,054 $ 280,002 $ 231,862
Earnings per share:        
Basic (in dollars per share) $ 3.05 $ 3.74 $ 11.32 $ 9.43
Diluted (in dollars per share) $ 3.02 $ 3.69 $ 11.21 $ 9.31
Weighted-average shares and equivalent shares outstanding:        
Basic (in shares) 24,755 24,622 24,726 24,582
Diluted (in shares) 24,988 24,926 24,986 24,904